The Medical Science Liaison (MSL) will serve as the field-based scientific expert whose mission is to foster collaborative relationships with opinion leaders focused on a rare hematologic disorder and to facilitate the exchange of unbiased scientific information between the medical community and the company. The MSL will have the clinical/medical affairs expertise to serve as a peer-to-peer liaison internally and externally. This role will be covering the Great Lakes territory: Ohio, West Virginia, Pennsylvania, Delaware, and New Jersey. This MSL role will start on February 16th or April 16th.